Article
Cardiac & Cardiovascular Systems
Andreas S. Papazoglou, Anastasios Kartas, Athanasios Samaras, Ioannis Vouloagkas, Eleni Vrana, Dimitrios V. Moysidis, Evangelos Akrivos, Georgios Kotzampasis, Amalia Baroutidou, Anastasios Papanastasiou, Evangelos Liampas, Michail Botis, Efstratios Karagiannidis, Nikolaos Stalikas, Haralambos Karvounis, Apostolos Tzikas, George Giannakoulas
Summary: The presence of diabetes mellitus on top of atrial fibrillation was associated with increased risk of all-cause mortality and cardiovascular mortality. Lower HbA1c levels were independently related to better survival rates in patients with atrial fibrillation and diabetes mellitus.
CARDIOVASCULAR DIABETOLOGY
(2021)
Review
Cardiac & Cardiovascular Systems
Andreas S. Papazoglou, Anastasios Kartas, Dimitrios Moysidis, Christos Tsagkaris, Stavros P. Papadakos, Alexandra Bekiaridou, Athanasios Samaras, Efstratios Karagiannidis, Marios Papadakis, George Giannakoulas
Summary: Atrial fibrillation and diabetes mellitus are two closely related chronic cardiovascular disorders with increasing prevalence rates. Diabetes not only precipitates the occurrence of atrial fibrillation, but also affects the clinical course and prognosis of established atrial fibrillation.
CARDIOVASCULAR DIABETOLOGY
(2022)
Article
Cardiac & Cardiovascular Systems
Moon-Hyun Kim, Hee Tae Yu, Yoon Jung Park, Tae-Hoon Kim, Boyoung Joung, Moon-Hyoung Lee, Hui-Nam Pak
Summary: This study aimed to explore the relationship between diabetes mellitus and a stiff left atrium (LA) physiology after atrial fibrillation (AF) catheter ablation (AFCA). The study found that patients with diabetes had higher peak LA pressure and greater LA wall stress, and were more likely to develop a stiff LA physiology. A stiff LA physiology was independently associated with diabetes, empirical extra-pulmonary vein LA ablation and Delta PVR.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Zhan Peng, Rui Zhao, Yuhua Liu, Yunxiao Yang, Xiubin Yang, Kun Hua
Summary: This study found that maintaining a downward trend in HbA1c during the 12-month period before the operation and having HbA1c < 7.5% at the time of the operation can reduce atrial fibrillation recurrence rates after heart valve surgery concomitant with Cox-Maze IV ablation. Patients with higher preoperative HbA1c levels and an upward trend in HbA1c were associated with higher recurrence rates.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Fangyuan Luo, Liping Sun, Zhe Wang, Yuekun Zhang, Jiaju Li, Yingwei Chen, Jianzeng Dong
Summary: In patients with type 2 diabetes, treatment with dapagliflozin appears to be independently associated with a significant reduction in the risk of recurrent atrial arrhythmias after radiofrequency catheter ablation.
CARDIOVASCULAR DRUGS AND THERAPY
(2022)
Article
Cardiac & Cardiovascular Systems
Husam Abdel-Qadir, Madison Gunn, Iliana C. Lega, Andrea Pang, Peter C. Austin, Sheldon M. Singh, Cynthia A. Jackevicius, Karen Tu, Paul Dorian, Douglas S. Lee, Dennis T. Ko
Summary: The longer the duration of diabetes and the higher the glycated hemoglobin level, the significantly higher the stroke rate in patients with AF and diabetes.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2022)
Article
Computer Science, Interdisciplinary Applications
Javier Saiz-Vivo, Valentina D. A. Corino, Alba Martin-Yebra, Luca T. Mainardi, Robert Hatala, Leif Sornmo
Summary: This study investigated the possibility of predicting post-ablation recurrence of atrial fibrillation (AF) by evaluating AF episode patterns. The results showed that high AF dominance and episode aggregation are associated with increased risk of AF recurrence, suggesting they can be used as risk assessment indicators before catheter ablation.
MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING
(2023)
Article
Cardiac & Cardiovascular Systems
Jonathan M. Kalman, Ahmed M. Al-Kaisey, Ramanathan Parameswaran, Joshua Hawson, Robert D. Anderson, Michael Lim, David Chieng, Stephen A. Joseph, Alex McLellan, Joseph B. Morton, Paul B. Sparks, Geoffrey Lee, Prashanthan Sanders, Peter M. Kistler
Summary: This study aimed to determine if the timing of catheter ablation for atrial fibrillation (AF) affects arrhythmia outcomes. The results showed that there was no significant difference in the atrial arrhythmia free survival at 12 months post-ablation between patients who underwent early ablation and those who underwent delayed ablation. Other secondary outcomes also showed no significant difference. Therefore, delaying AF ablation by 12 months for antiarrhythmic drug management does not reduce the efficacy of ablation.
EUROPEAN HEART JOURNAL
(2023)
Article
Cardiac & Cardiovascular Systems
Alexander Kogan, Avishay Grupper, Avi Sabbag, Eilon Ram, Tamer Jamal, Eyal Nof, Enrique Z. Fisman, Shany Levin, Roy Beinart, Jonathan Frogel, Ehud Raanani, Leonid Sternik
Summary: The study evaluated the impact of type 2 diabetes on the outcomes of patients undergoing surgical atrial fibrillation ablation. The results showed that the freedom from atrial fibrillation and 1-3 year mortality after surgical ablation were similar in non-diabetic and type 2 diabetes patients, but the 5-year mortality was higher in the type 2 diabetes group.
CARDIOVASCULAR DIABETOLOGY
(2023)
Article
Medicine, General & Internal
Denise Guckel, Khuraman Isgandarova, Leonard Bergau, Misagh Piran, Mustapha El Hamriti, Guram Imnadze, Martin Braun, Moneeb Khalaph, Thomas Fink, Vanessa Sciacca, Georg Noelker, Young-Hee Lee-Barkey, Diethelm Tschoepe, Philipp Sommer, Christian Sohns
Summary: This study evaluated the outcome of pulmonary vein isolation (PVI) using a single-shot device in patients with atrial fibrillation (AF) and diabetes mellitus (DM). Results showed that diabetes mellitus was associated with a higher risk of arrhythmia recurrence after PVI, with more pronounced effects in paroxysmal AF compared to persistent AF. Personalized approaches addressing individual arrhythmia substrates may be necessary for this specific cohort of patients.
JOURNAL OF CLINICAL MEDICINE
(2021)
Review
Cardiac & Cardiovascular Systems
Gianluigi Bisleri, Arjun K. Pandey, Subodh Verma, Syed M. Ali Hassan, Bobby Yanagawa, Masud Khandaker, Mario Gaudino, Andrea M. Russo, Atul Verma, Deepak L. Bhatt, Andrew C. T. Ha
Summary: Hybrid ablation is a novel therapy that combines minimally invasive surgical and percutaneous catheter-based techniques for the management of atrial fibrillation (AF). Observational studies have shown approximately 70% success rates but higher risks compared to catheter-based ablation. Hybrid ablation is typically offered to patients with persistent or longstanding persistent AF, requiring two procedures. While a randomized trial demonstrated its superiority over catheter-based ablation, it also showed higher complication rates. Contemporary studies have shown a decrease in the incidence of serious complications. Additional randomized trials are needed to determine the risks, benefits, and cost effectiveness of hybrid ablation in clinical practice.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2023)
Article
Cardiac & Cardiovascular Systems
Geoffroy Ditac, Pierre Jean Cottinet, Minh Quyen Le, Daniel Grinberg, Josselin Duchateau, Kevin Gardey, Arnaud Dulac, Antoine Deliniere, Christelle Haddad, Julie Boussuge-Roze, Frederic Sacher, Pierre Jais, Philippe Chevalier, Francis Bessiere
Summary: Atrial fibrillation (AF) catheter ablation procedure contributes significantly to GHG emissions, with a carbon footprint of 76.9 kg CO2-e. With approximately 600,000 annual procedures worldwide, AF catheter ablation leads to 125 tons of CO2 emissions every day, equivalent to a daily car ride of 700,000 km. Electrophysiology catheters and patches are identified as the main contributors to the carbon footprint, highlighting the importance of reducing, reusing, and recycling these items.
Article
Cardiac & Cardiovascular Systems
Sung Hwa Choi, Hee Tae Yu, Daehoon Kim, Je-Wook Park, Tae-Hoon Kim, Jae-Sun Uhm, Boyoung Joung, Moon-Hyoung Lee, Chun Hwang, Hui-Nam Pak
Summary: This study aims to explore the mechanism of long-term recurrence in patients with atrial fibrillation (AF). The findings suggest that patients with a later recurrence of AF have smaller left atrial volume, lower left atrial voltage, and more extra-pulmonary vein triggers during the repeat procedure.
Article
Cardiac & Cardiovascular Systems
Karim Benali, Paul Khairy, Nefissa Hammache, Adrian Petzl, Antoine Da Costa, Atul Verma, Jason G. Andrade, Laurent Macle
Summary: A systematic review and pooled analysis of randomized control trials showed that catheter ablation of atrial fibrillation is associated with low rates of procedure-related complications and mortality, which have declined over the past decade.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2023)
Article
Endocrinology & Metabolism
Gabriela Correia Uliana, Lediane Nunes Camara, Carla Cristina Paiva Paracampo, Juliana Carvalho da Costa, Daniela Lopes Gomes
Summary: This study aims to analyze the characteristics of carbohydrate counting (CC) practice and its association with glycated hemoglobin (HbA1c) adequacy in adults with type 1 diabetes mellitus (T1DM) in Brazil. The results show that participants who practice CC and have a duration of diabetes less than 10 years are more likely to have adequate HbA1c levels.
FRONTIERS IN ENDOCRINOLOGY
(2023)